Advertisement

Rheumatology International

, Volume 11, Issue 2, pp 45–50 | Cite as

Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis

  • M. Field
  • C. Chu
  • M. Feldmann
  • R. N. Maini
Originals

Summary

Polyclonal antibodies were raised in rabbits against Interleukin-6 (IL-6) by immunisation with a synthetic peptide of identical sequence to the amino terminal 12 amino acids of human IL-6. These antibodies reacted with recombinant IL-6 by ELISA and stained the cytoplasm of the IL-6 secreting bladder tumour cell line T24. Staining was abolished by prior incubation of the antibody with the IL-6 peptide. F(ab′)2 fragments made by pepsin digestion of the IgG were immunopurified, labelled with biotin and retained activity in the biochemical and histological assays. Sections of synovial membrane from patients with rheumatoid arthritis (RA) were stained with these antibodies, using an immunoperoxidase technique, and cells containing IL-6 were domonstrated in the thickened synovial lining layer and also in a perivascular distribution in the deeper synovium. In osteoarthritis there were fewer cells in the lining layer and hence localisation appeared similar in both the interstitial area and lining layer. Double-staining techniques with mouse monoclonal antibodies against cell subset markers in five RA synovial membranes showed that up to 13% of T-cells and 19% of antibody-producing cells stained or IL-6. However, up to 70% of the macrophages contained IL-6 and these were found in close proximity to lg-producing plasma cells. This study showed that Anacrophages were the major cells of the immune system in which IL-6 could be localised in RA, and suggests a cole for locally produced IL-6 in the stimulation of theumatoid factor production.

Key words

Interleukin-6 Rheumatoid arthritis Synovial membrane Immunohistology Autommune discase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Poupart P, Vandenabeele P, Cayphas S, Van Snick J, HaegemanG, Kruys V, Fiers W, Content J (1987) B cell growth modulating and differentiating activity of recombinant human 26 kd protein (BSF-2 HuIFN β2, HPGF). EMBO J 6:1219–1224Google Scholar
  2. 2.
    Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76Google Scholar
  3. 3.
    Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84:228–231Google Scholar
  4. 4.
    Gauldie J, Richards C, Harnish D, Landsdorp P, Baumann H (1987) Interferon β2, shares identity with monocyte derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251–7255Google Scholar
  5. 5.
    Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini RN, Feldmann M, Kishimoto T (1988) Excessive production of Interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797–1801Google Scholar
  6. 6.
    Houssiau FA, Devogelaer J-P, Van damme J, De Deuxchaisnes CN, Van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784–788Google Scholar
  7. 7.
    Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265–336Google Scholar
  8. 8.
    Lindblad S, Hedfors E (1987) The synovial membrane of healthy individuals — immunohistochemical overlap with synovitis. Clin Exp Immunol 69:41–47Google Scholar
  9. 9.
    Burmester GR, Locher P, Koch B, Winchester RJ, Dimitriu-Bona A, Kalden JR, Mohr W (1983) The tissue architecture of synovial membranes in inflammatory and non inflammatory joint diseases. Rheumatol Int 3:173–181Google Scholar
  10. 10.
    Klareskog L, Forsum U, Wigren A, Wigzell H (1982) Relationships between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid arthritis synovial tissue. Scand J Immunol 15:501–507Google Scholar
  11. 11.
    Mellors RC, Heimer R, Corcos J, Korngold L (1959) Cellular origin of rheumatoid factor. J Exp Med 110:875–886Google Scholar
  12. 12.
    Natvig JB, Munthe E (1975) Self-associating IgG rheumatoid factor represents a major response of plasma cells in rheumatoid inflammatory tissue. Ann NY Acad Sci 256:88–95Google Scholar
  13. 13.
    Sehgal PB, May LT, Tamm I, Vilcek J (1987) Human β2 interferon and B cell differentiation factor BSF-2 are identical. Science 235:731–732Google Scholar
  14. 14.
    Zeheb R, Chang V, Orr GA (1983) An analytical method for the selective retrieval of iminobiotin-derivatized plasma membrane proteins. Anal Biochem 129:156–161Google Scholar
  15. 15.
    Rawle FC, Shields J, Smith SH, Iliescu V, Merkenschlager M, Beverley PCL, Callard RE (1986) B cell growth and differentiation induced by supermatants of transformed epithelial cell lines. Eur J Immunol 16:1017–1019Google Scholar
  16. 16.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Freis JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324Google Scholar
  17. 17.
    Hogg N, Macdonald S, Slusarenko M, Beverley PCL (1984) Monoclonal antibodies specific for human monocytes, granulocytes granulocytes and endothelium. Immunology 53:753–767Google Scholar
  18. 18.
    Ugolini V, Nunez G, Graham-Smith R, Stastny P, Capra JD (1980) Initial characterisation of monoclonal antibodies against human monocytes. Proc Natl Acad Sci USA 77:6764–6768Google Scholar
  19. 19.
    Klareskog L, Forsum U, Wigzell H (1982) Murine synovial intima contains I-A, I-E/C positive bone marrow derived cells. Scand J Immunol 15:509–514Google Scholar
  20. 20.
    Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, Mantovani A (1989) IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142:549–553Google Scholar
  21. 21.
    Aarden L, de Groot E, Schaap O,Landsdorp P (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416Google Scholar
  22. 22.
    Nakajima K, Martinez-Maza O, Hirano T, Breen EC, Nishanian PG, Salazar-Gonzalez JR, Fahey J, Kishimoto T (1989) Induction of IL-6 (B cell stimulatory factor-2/IFN-β2) production by HIV. J Immunol 142:531–536Google Scholar
  23. 23.
    Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT (1988) Regulation of the acute phase and immune responses in viral disease. J Exp Med 167:1951–1956Google Scholar
  24. 24.
    Kohase M, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB (1986) Induction of β2 by tumour necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666Google Scholar
  25. 25.
    Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Van Snick J (1987) Identification of the human 26-kD protein, interferon β2 (INF-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumour necrosis factor. J Exp Med 165:914–919Google Scholar
  26. 26.
    Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M (1988) Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 73:449–455Google Scholar
  27. 27.
    Husby G, Williams RC (1988) Synovial localisation of tumour necrosis factor in patients with rheumatoid arthritis. J Autoimmunity 1:363–371Google Scholar
  28. 28.
    Chu CC, Field M, Feldmann M, Maini RN (resubmitted) Localisation of TNFα in rheumatoid synovial membrane and cartilage/pannus junction. Arthritis RheumGoogle Scholar
  29. 29.
    Brennan FM, Chantry D, Jackson A, Maini RN, Feldmann M (1989) Inhibitory effects of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet II:244–247Google Scholar
  30. 30.
    Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1988) B cell stimulating factor/Interleukin-6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 167:1253–1258Google Scholar
  31. 31.
    Neitfield JJ, Helle M, Wilbrink B, Van Roy JLAM, Boeije LMC, Den Otter W, Aarden LA, Huber-Bruning O (1989) The effect of IL-1 on human articular cartilage is counteracted by antibodies against IL-6 (abstract). Clin Rheumatol 8:38–39Google Scholar
  32. 32.
    Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T (1987) Rheumatoid factor secretion from human Leu-1+ B cells. Science 236:813Google Scholar
  33. 33.
    Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Jannosy G (1985) A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum 28:971–976Google Scholar
  34. 34.
    Cecere P, Lessard J, McDuffy S, Pope RM (1982) Evidence for the local production and utilisation of immune reactants in rheumatoid arthritis. Arthritis Rheum 25:1307–1315Google Scholar
  35. 35.
    Rowley MJ, Williamson DJ, Mackay IR (1987) Evidence for the local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 30:1420–1425Google Scholar
  36. 36.
    Chantry D, Winearls CG, Maini RN, Feldmann M (1989) Mechanisms of immune complex mediated damage: Induction of IL-1 by immune complexes and synergy with interferon-γ and tumour necrosis factor. Eur J Immunol 19:189–192Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • M. Field
    • 1
  • C. Chu
    • 1
  • M. Feldmann
    • 2
  • R. N. Maini
    • 1
  1. 1.Clinical Immunology DivisionMatilda and Terence Kennedy Institute of RheumatologyLondonUK
  2. 2.Charing Cross Sunley Research CentreLondonUK

Personalised recommendations